정밀 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Precision Diagnostics Market size is expected to reach USD 112.35 Billion in 2034 from USD 23.55 Billion (2025) growing at a CAGR of 18.96% during 2026-2034.

The global precision diagnostics market is growing rapidly as healthcare systems focus on personalized medicine and targeted treatment approaches. Precision diagnostics involves using advanced technologies such as genetic testing, molecular diagnostics, and biomarker analysis to identify diseases more accurately. These tools help doctors select the most effective treatments for individual patients.

One of the major drivers of the market is the increasing prevalence of chronic diseases such as cancer and genetic disorders. Healthcare providers are adopting advanced diagnostic tools to detect diseases at an early stage and develop personalized treatment plans. Growing investments in biotechnology research and genomic technologies are also supporting market expansion.

In the future, the precision diagnostics market is expected to expand significantly as healthcare moves toward personalized and data-driven treatment strategies. Advances in genomic sequencing, artificial intelligence, and digital health technologies will improve diagnostic accuracy. As healthcare providers focus more on early detection and precision medicine, demand for advanced diagnostic solutions will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

By Application

• Oncology
• Respiratory Diseases
• Skin Diseases
• CNS Disorders
• Immunology
• Genetic Diseases
• Others
• By-End-use
• Hospitals
• Clinical Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, bioMrieux SA, Becton, Dickinson and Company, Danaher Corporation, QIAGEN NV, Hologic Inc, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Direct to Consumer Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Esoteric Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Skin Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CNS Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Genetic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION DIAGNOSTICS MARKET: BY BY-END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast By-end-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By By-end-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By By-end-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By By-end-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By By-end-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By By-end-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRECISION DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 F. Hoffmann-La Roche Ltd
  • 9.2.3 Siemens Healthineers AG
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 BioMerieux SA
  • 9.2.6 Becton, Dickinson And Company
  • 9.2.7 Danaher Corporation
  • 9.2.8 QIAGEN N.V
  • 9.2.9 Hologic Inc
  • 9.2.10 Agilent Technologies Inc